about
Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammationQuercetin protects against obesity-induced skeletal muscle inflammation and atrophy.Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal MacrophagesReverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.Anti-CD137 mAb Deletes Both Donor CD4 and CD8 T Cells in Acute Graft-versus-host Disease.4-1BB/4-1BBL interaction promotes obesity-induced adipose inflammation by triggering bidirectional inflammatory signaling in adipocytes/macrophages.Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.Blockade of 4-1BB and 4-1BBL interaction reduces obesity-induced skeletal muscle inflammation.Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand.Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters.Novel CD137 Gene Polymorphisms and Susceptibility to Ischemic Stroke in the Northern Chinese Han Population.The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response?
P2860
Q27022830-E21C0792-738A-4967-9634-666521D21BE7Q34970397-E1B0E54C-0938-42B5-A0F8-1A64C140291FQ35456337-D0CC6385-002A-42BF-94AD-F8C11D1A3193Q35657838-D3C66951-255F-4BD8-A0E8-C051463BD6F0Q35745542-53405B6F-4866-4B5A-B6F0-E6E49F4675E5Q36500294-6E1A2D02-5D4B-4DEE-88E2-D9BA20281960Q37224656-AEA3A62C-EA4C-4B86-A5E4-4119981AEAA7Q37433264-00BEFFEF-9B71-4D74-A1C1-FE2D0A6F8BEEQ37785736-1209C248-86EC-452E-9E67-8B45A7378BA3Q38406177-82A05714-4563-4977-8457-F41A131F2AA1Q38915465-CC82203A-BBAF-474B-B381-1663619AC116Q40184385-D750DFAA-B147-4B7E-B8A0-66EA04879288Q42364296-1E084DDB-A8CA-4932-99F8-FA03E934D1B2Q45170299-A3E87F34-88EE-4030-8099-9004EE292B25Q48326988-7A114D36-C9AC-4CB8-9EAB-8FDE01A4E297Q55162275-65236199-C1CA-4595-A633-A37EB38D4F56
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
CD137-CD137 Ligand Interactions in Inflammation.
@en
CD137-CD137 Ligand Interactions in Inflammation.
@nl
type
label
CD137-CD137 Ligand Interactions in Inflammation.
@en
CD137-CD137 Ligand Interactions in Inflammation.
@nl
prefLabel
CD137-CD137 Ligand Interactions in Inflammation.
@en
CD137-CD137 Ligand Interactions in Inflammation.
@nl
P2860
P356
P1433
P1476
CD137-CD137 Ligand Interactions in Inflammation.
@en
P2093
Byungsuk Kwon
P2860
P356
10.4110/IN.2009.9.3.84
P577
2009-06-30T00:00:00Z